FGFR2 rearrangements
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | FGFR2 rearrangements | Cholangiocarcinoma | Pemigatinib | |
| EMA (1) | FGFR2 rearrangements | Cholangiocarcinoma | Futibatinib | |
| EMA (1) | FGFR2 rearrangements | Cholangiocarcinoma | Elacestrant |